Table 4.

Association of lipid-lowering medication use and duration of use with fatal prostate cancer, 6,518 men in ARIC (1990–2012)

# Prostate cancer deathsPerson-yearsHRa (95% CI)HRb (95% CI)
Current use
 No5374,0071 (Ref)1 (Ref)
 Yes3740,5340.64 (0.41–1.02)0.67 (0.42–1.07)
Duration of use
 Never5374,0071 (Ref)1 (Ref)
 <10 years2227,9530.62 (0.37–1.04)0.64 (0.38–1.08)
 ≥10 years1512,5800.69 (0.37–1.30)0.74 (0.39–1.40)
  • aAdjusted for age and joint categories of race and field center.

  • bAdjusted for age, joint categories of race and field center, height, updated BMI, updated cigarette smoking status, updated diabetes status, updated aspirin use, and education level.